LINVESTA EMP 5/25MG TAB

LINVESTA EMP 5/25MG is a combination tablet containing Linagliptin and Empagliflozin, designed to help manage type 2 diabetes. Linagliptin works by increasing insulin release when blood sugar is high, while Empagliflozin helps the kidneys remove excess glucose through urine. This dual-action formula supports better blood sugar control and may help reduce the risk of heart and kidney complications in diabetic patients. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.